Broncus Technologies Registers for IPO |
Houston Chronicle - Nov 20, 2007 |
Broncus Technologies Inc., which develops minimally invasive medical devices for emphysema and other lung diseases, plans an initial public offering of its common stock, according to a Securities and Exchange Commission filing Tuesday.
The Mountain View, Calif.-based company did not disclose the expected number or price range of shares to be sold in the IPO but indicated the offering price could total up to $86.3 million.
Broncus noted the total offering price was estimated solely to calculate its registration fee and may change.
The company's catheter-based "Airway Bypass" procedure is used to treat emphysema patients by creating new passages in the lungs to bypass collapsed airways and allow trapped air to exit the lungs.
Read Full Article from Houston Chronicle
- Posted: 2007-11-20 10:09:00
More Stock Investor Place Financial News |
|
|
|
Stock Investor Place Financial News Archive |
|
|